NERVGEN PHARMA CORP. Current Assets
NERVGEN PHARMA CORP. (NGEN) had Current Assets of CAD 22.80 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-03-31
- 2025-12-31: Current Assets 22.80M CAD.
- 2024-12-31: Current Assets 19.01M CAD.
| Period end | Current Assets |
|---|---|
| 2025-12-31 | 22.80M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 19.01M CAD 40-F · filed 2026-03-31 |